Organs-On-Chips Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

An organ-on-chip refers to a microfluidic cell culture device with continuously perfused chambers. This chip creates a narrow channel for blood and airflow in organs like the lung, heart, liver, intestine, and others. These devices generate multiple levels of tissue and organ functionality that are not possible with traditional 2D and 3D culture systems. It has numerous applications, including patient stratification, disease modelling, and phenotypic screening. Moreover, rising need for alternatives to animal testing, increasing demand for early detection of drug toxicity, as well as new product launches and technological advancements are the crucial factors propelling the market growth. For instance, in December 2020, CN Bio and the University of Melbourne collaborated to develop therapies through the lung-on-a-chip technology for respiratory complications among patients who have recovered from COVID-19. Furthermore, the mounting demand for personalized medication and wide-range applications of organ-on-chip beyond the pharmaceutical industry are the crucial factors providing lucrative opportunities for market growth.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18572

According to UnivDatos Market Insights (UMI)’ research report “Organs-On-Chips Market”, the market is expected to witness a CAGR growth of around 32% during the forecast period 2021-2027F. The surge in applications of organ-on-chip devices in the healthcare sector and burgeoning demand for organ-on-chip in drug screening & lung- and kidney-based organ culture are the major factors influencing global organ-on-chip market growth. Organ-on-chip technologies are beneficial in real-time imaging and in-vitro studies of biochemical, genetic, and metabolic activities of living cells in a functional tissue, which further proliferates its adoption.

Based on Organ Type, the Organs-On-Chips market is categorized into Heart, Liver, Lung, and Others. Among these segments, the heart segment is expected to exhibit higher potential for the market growth owing to the rising incidences of cardiovascular diseases. However, Lung segment dominated the global organ-on-chip market and is maintain its dominance during the forecast period.

Based on Application, the market is bifurcated into Drug Discovery, Toxicology Research, Physiological Model Development, and Others. With the increasing costs associated with the development of new drugs, rising competition, and availability of limited time to peak sales, the importance of getting a drug launch right is becoming greater. Hence, the need for organ-on-chip for drug discovery is increasing dramatically in the market.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18572

North America Dominates the Market

Based on regions, the report provides detailed analysis for overall demand of Organs-On-Chips for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Indonesia, Bangladesh Rest of Asia-Pacific); and Rest of World.  

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Organs-On-Chips Market are MIMETAS BV, SynVivo Inc., Emulate Inc., InSphero AG, CN Bio, Nortis Inc., Organovo Holdings Inc., TissUse GmbH, AxoSim Inc., Kirkstall Ltd.  

“Organs-On-Chips Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go to market strategies and identifying the blue ocean for its offerings.      

Market Segmentation:

1.     By Organ Type (Heart, Liver, Lung, Others)

2.     By Application (Drug Discovery, Toxicology Research, Physiological Model Development, Others)

3.     By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others)

4.     By Region (North America, Europe, Asia-Pacific, Rest of World)

5.     By Company (MIMETAS BV, SynVivo Inc., Emulate Inc., InSphero AG, CN Bio, Nortis Inc., Organovo Holdings Inc., TissUse GmbH, AxoSim Inc., Kirkstall Ltd.)

For more informative information, please visit us @ https://univdatos.com/report/organs-on-chips-market/

Key questions answered in the study:

1.     What are the current and future trends of the Organs-On-Chips industry?

2.     How the industry has been evolving in terms of distribution channel and product category?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the Organs-On-Chips industry?

5.     What is the customer orientation, purchase behavior, and expectations from the Organs-On-Chips product suppliers across various countries?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 ORGANS-ON-CHIPS MARKET COVID-19 IMPACT

6 ORGANS-ON-CHIPS MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY ORGAN TYPE

8 MARKET INSIGHTS BY APPLICATION

9 MARKET INSIGHTS BY END-USER

10 MARKET INSIGHTS BY REGION

11 ORGANS-ON-CHIPS MARKET DYNAMICS

12 ORGANS-ON-CHIPS MARKET OPPORTUNITIES

13 ORGANS-ON-CHIPS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       MEA IVF Tools and Techniques Market to Reach US$ 3,164.7 Million by 2027 |CAGR: 16.3%|

·       Smart Syringe Market to exceed US$ 14.4 Billion by 2027 Globally |CAGR: 9.6%|

·       Smart Inhalers Market to exceed US$ 1.75 Billion by 2028 Globally |CAGR: 20.5%|

·       Mental Health Apps Market to Exceed USD 3.3 Billion by 2027 Globally |CAGR: 20.5%|